PharmaCorp Rx Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, PharmaCorp Rx stock has a consensus rating of "Strong Buy" and an average price target of $0.67. The average 1-year stock price forecast is 34.00% higher than the current stock price, while the lowest is $0.60 (+20.00%) and the highest is $0.70 (+40.00%).

Price Target: $0.67 (+34.00%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$0.60	$0.67	$0.70	$0.70
Change	+20.00%	+34.00%	+40.00%	+40.00%

* Price targets were last updated on Jun 2, 2026.

Analyst Ratings

The average analyst rating for PharmaCorp Rx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	May '26	Jun '26
Strong Buy	1	1	1	2
Buy	0	0	0	1
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	1	1	1	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Fred Gatali‏ Raymond James No rating	Raymond James	Buy Initiates $0.70	Buy	Initiates	$0.70	+40.00%	Jun 2, 2026

Financial Forecast

Revenue This Year

48.54M

from 20.89M

132.33%

from 20.89M

Revenue Next Year

96.12M

from 48.54M

98.00%

from 48.54M

EPS This Year

0.01

from -0.01

EPS Next Year

0.03

from 0.01

299.85%

from 0.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	5.79M	20.89M	48.54M
Revenue Growth	-	-	-	-	260.57%	132.33%
Gross Profit	-	-	-	2.18M	8.30M	19.26M
Gross Margin	-	-	-	37.69%	39.72%	39.67%
Operating Income	-79.60K	-563.18K	-577.96K	-1.59M	-1.24M	2.22M
Net Income	-77.45K	-517.09K	-470.43K	-1.01M	-1.48M	2.00M
EPS	-	-	-	-	-0.01	0.01
Forward PE	-	-	-	-	-	74.96
Free Cash Flow	-	44.92K	-410.26K	-543.98K	1.85M	-2.33M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue	2026	2027	2028
High	52.0M
Avg	48.5M
Low	41.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	148.9%
Avg	132.3%
Low	100.5%

EPS Forecast

EPS	2026	2027	2028
High	0.01
Avg	0.01
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-